| East Florida Behavioral Health Network, Llc | |
|
2201 45th St West Palm Beach FL 33407-2047 | |
| (561) 863-3824 | |
| Not Available |
| Full Name | East Florida Behavioral Health Network, Llc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 2201 45th St, West Palm Beach, Florida |
| Authorized Official Name and Position | Angela W Brady (AVP OPERATIONS) |
| Authorized Official Contact | 8438136397 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| East Florida Behavioral Health Network, Llc 111 Jfk Dr Ste A Atlantis FL 33462-6634 Ph: (561) 548-3716 | East Florida Behavioral Health Network, Llc 2201 45th St West Palm Beach FL 33407-2047 Ph: (561) 863-3824 |
| NPI Number | 1538462130 |
|---|---|
| Provider Enumeration Date | 12/21/2010 |
| Last Update Date | 12/21/2010 |
| Medicare PECOS PAC ID | 7810160249 |
|---|---|
| Medicare Enrollment ID | O20111101000221 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538462130 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Primary |
| Provider Name | Robert F Vassall |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1639254147 PECOS PAC ID: 9133160070 Enrollment ID: I20050520000261 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Peter Theodoropoulos |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1790814713 PECOS PAC ID: 2567486442 Enrollment ID: I20060118000653 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Nelson Anibal Hernandez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1326082249 PECOS PAC ID: 9436153830 Enrollment ID: I20060825000366 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Krithika S Iyer |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1588753438 PECOS PAC ID: 9436245099 Enrollment ID: I20071012000546 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Marie Addly Cambronne |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1639372543 PECOS PAC ID: 0345338802 Enrollment ID: I20071116000091 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Clara Alvarez Villalba |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497802839 PECOS PAC ID: 5395895411 Enrollment ID: I20090611000491 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Maria D Del Sol |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1184793341 PECOS PAC ID: 5890837967 Enrollment ID: I20100127000940 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Richard Allan Callahan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1215378336 PECOS PAC ID: 4587886221 Enrollment ID: I20141112001350 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Samuel Neuhut |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1750609244 PECOS PAC ID: 4082928015 Enrollment ID: I20150804003859 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Khairul S Alam |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1801864434 PECOS PAC ID: 9234034117 Enrollment ID: I20150910002065 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Ana Suarez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1164706404 PECOS PAC ID: 8921317819 Enrollment ID: I20151015001008 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | John Md Naliyath |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1912268301 PECOS PAC ID: 6709196066 Enrollment ID: I20151117001776 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Adriana Foster |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1467562942 PECOS PAC ID: 4981650967 Enrollment ID: I20151208001748 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Joseph C Brock |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1194288316 PECOS PAC ID: 9931435583 Enrollment ID: I20230715000773 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
| Provider Name | Sindhura Kompella |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1316444953 PECOS PAC ID: 0042671489 Enrollment ID: I20230801002256 |
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
News Archive
The first known identification of two genes responsible for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect, has been reported by researchers at the University of Pittsburgh School of Medicine.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Co-principal investigators Richard McCallum, M.D., and Irene Sarosiek, M.D., have received a five-year, $1.8 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
› Verified 8 days ago
Rehab South Florida Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4460 Medical Center Way, West Palm Beach, FL 33407 Phone: 863-532-3151 | |
Salonia Psychotherapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1825 Forest Hill Blvd., #105, West Palm Beach, FL 33406 Phone: 954-650-6907 | |
Sunshine Of Tomorrow Behavioral Care Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7711 N Military Trl Ste 204, West Palm Beach, FL 33410 Phone: 561-914-4104 | |
Diosark, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1546 42nd St, West Palm Beach, FL 33407 Phone: 561-840-1647 Fax: 561-840-6415 | |
Crossroads Counseling Center Of The Palm Beaches Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1825 Forest Hill Blvd, Suite 105, West Palm Beach, FL 33406 Phone: 561-722-7084 Fax: 561-697-9925 | |
Wellbeing Therapy Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7750 Okeechobee Blvd # 4-76, West Palm Beach, FL 33411 Phone: 772-678-0341 | |
Be Free Stay Free Family & Individual Therapy Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3626 Whitehall Dr Apt 206, West Palm Beach, FL 33401 Phone: 561-377-2373 |